APA

van Linde M. E., Verhoeff J. J. C., Richel D. J., van Furth W. R., Reijneveld J. C., Verheul H. M. W. & Stalpers L. J. A. (20151204). Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme. : The oncologist.

Chicago

van Linde Myra E, Verhoeff Joost J C, Richel Dirk J, van Furth Wouter R, Reijneveld Jaap C, Verheul Henk M W and Stalpers Lukas J A. 20151204. Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme. : The oncologist.

Harvard

van Linde M. E., Verhoeff J. J. C., Richel D. J., van Furth W. R., Reijneveld J. C., Verheul H. M. W. and Stalpers L. J. A. (20151204). Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme. : The oncologist.

MLA

van Linde Myra E, Verhoeff Joost J C, Richel Dirk J, van Furth Wouter R, Reijneveld Jaap C, Verheul Henk M W and Stalpers Lukas J A. Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme. : The oncologist. 20151204.